Skip to content
Parakho

Gaudium IVF and Women Health Ltd

NSE GAUDIUMIVFBSE 544709gaudiumivfcentre.com

Q1 FY27, unaudited

Revenue
₹19.38 Cr
Profit after tax
₹1.78 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations19.38—104.36
Other income1.12—0.53
Total income20.50—104.89
Employee benefit expense2.28—7.99
Finance costs0.38—3.49
Depreciation & amortisation0.72—2.55
Total expenses18.05—72.69
Profit before tax2.45—32.20
Tax expense0.67—7.71
Profit after tax1.78—24.46
Total comprehensive income1.80—24.54
Earnings per share
Earnings per share, basic₹0.25₹3.92
Earnings per share, diluted₹0.25₹3.92

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Why the dash

Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.

Earnings call

A transcript for the Q1 FY27 call was filed with the exchange; Parakho has not summarised it yet.

All quarters

Filings

12 shown · 39 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 19 Aug 2026.